APT(SH:688617) Sou Hu Cai Jing·2025-07-01 11:21Company Overview - Shenzhen Huatai Medical Devices Co., Ltd. specializes in the research, production, and sales of electrophysiological and interventional medical devices [1] - The main products include electrophysiological devices, coronary access devices, peripheral vascular interventional devices, and non-vascular interventional medical devices [1] Financial Performance - For Q1 2025, the company reported revenue of 564 million yuan, representing a year-on-year increase of 23.93% [1] - The net profit for the same period was 183 million yuan, showing a year-on-year growth of 30.69% [1] - The gross profit margin stood at 73.09% [1] Market Position - As of July 1, the company's stock closed at 304.5 yuan, with a price increase of 2.53% [1] - The rolling price-to-earnings (PE) ratio reached 59.96 times, while the average PE ratio for the medical device industry is 51.70 times [1][2] - The total market capitalization of the company is 42.939 billion yuan [1] Institutional Holdings - As of Q1 2025, a total of 109 institutions hold shares in Huatai Medical, including 106 funds and 3 other entities, with a total holding of 47.1568 million shares valued at 18.264 billion yuan [1]